(Q40469006)

English

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.

scientific article published on October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

0 references

0 references

0 references

Democratic Republic of the Congo

0 references

0 references

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Swarthout TD

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

van den Broek IV

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kayembe G

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Montgomery J

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pota H

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tropical Medicine and International Health

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1503-1511

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Assessing the efficacy of chloroquine and sulfadoxine–pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Antimalarial treatment with artemisinin combination therapy in Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Combination therapy for malaria: the way forward?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Effects of artemisinin derivatives on malaria transmissibility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01710.X

21 January 2018

Identifiers

10.1111/J.1365-3156.2006.01710.X

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40469006&oldid=1494059399"